JANUMET XR 500 mg/1

Janumet XR 500 mg/1 combines sitagliptin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Janumet XR 500 mg/1 is commonly used to help manage blood sugar levels in adults with type 2 diabetes. The combination of sitagliptin and metformin hydrochloride works to improve glycemic control when diet and exercise alone are not sufficient. This extended-release tablet is designed to provide consistent blood sugar management throughout the day.

Common effects of Janumet XR 500 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headache or upper respiratory tract infection. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Janumet XR 500 mg/1 should be handled with care, especially for individuals with kidney or liver issues. It is important to stay hydrated and monitor blood sugar levels regularly. This medication should be taken as directed, and any changes in dosage or administration should be discussed with a healthcare provider.

Janumet XR 500 mg/1 may interact with certain medications, including those that affect kidney function or other diabetes treatments. Alcohol consumption should be limited, as it can increase the risk of low blood sugar. Always inform healthcare providers about all medications being taken to avoid potential interactions.